This study aims to investigate whether follow-up with a psychologist has an impact on the outcome of patients with an implantable automated defibrillator.
The implantation of an ICD in primary prevention is known to increase the rates of anxiety and depression, which can reach up to 45% and 35% respectively in this patient population. Several studies have reported that psychological accompaniment for these patients can alleviate the symptoms of anxiety and/or depression. Therefore, we aim to investigate the utility of psychological follow-up for a period of 1 year after first implantation of an ICD for primary prevention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
18
Individual, recorded interview with a qualified psychologist to discuss any and all subjects related to the ICD implantation, or any other topics deemed relevant by the patient.
CHU Besancon
Besançon, Besancon, France
Mini International Neuropsychiatric Interview score
Time frame: 48 hours after implantation
Mini International Neuropsychiatric Interview score
Time frame: 2 weeks after implantation
Mini International Neuropsychiatric Interview score
Time frame: 2 months after implantation
Mini International Neuropsychiatric Interview score
Time frame: 4 months after implantation
Mini International Neuropsychiatric Interview score
Time frame: 6 months after implantation
Mini International Neuropsychiatric Interview score
Time frame: 12 months after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
Time frame: 48 hours after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
Time frame: 2 weeks after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
Time frame: 2 months after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 4 months after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
Time frame: 6 months after implantation
Quality of life
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
Time frame: 12 months after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 48 hours after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 2 weeks after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 2 months after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 4 months after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 6 months after implantation
State-Trait Anxiety Inventory
Measure of state and trait anxiety
Time frame: 12 months after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 48 hours after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 2 weeks after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 2 months after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 4 months after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 6 months after implantation
Minnesota Living with Heart Failure questionnaire
Evaluation of the quality of life in patients with heart failure
Time frame: 12 months after implantation